BELLEVUE ASSET MANAGEMENT, LLC - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 177 filers reported holding ROCKET PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.35 and the average weighting 0.5%.

Quarter-by-quarter ownership
BELLEVUE ASSET MANAGEMENT, LLC ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$1,000
-50.0%
340.0%0.00%0.0%
Q2 2021$2,0000.0%34
-10.5%
0.00%0.0%
Q1 2021$2,000
+100.0%
38
+58.3%
0.00%0.0%
Q4 2020$1,000240.00%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 16,037,486$280,250,00019.13%
TANG CAPITAL MANAGEMENT LLC 2,965,485$52,015,0009.58%
Boxer Capital, LLC 1,466,051$25,715,0002.97%
Ghost Tree Capital, LLC 600,000$10,524,0002.75%
BRIDGER MANAGEMENT, LLC 1,529,032$26,819,0002.12%
Cormorant Asset Management, LP 1,700,000$29,818,0002.02%
EcoR1 Capital, LLC 450,000$7,893,0000.73%
UNIVERSITY OF NOTRE DAME DU LAC 171,015$3,000,0000.67%
Virtus ETF Advisers LLC 17,799$312,0000.66%
SPHERA FUNDS MANAGEMENT LTD. 290,001$5,087,0000.46%
View complete list of ROCKET PHARMACEUTICALS INC shareholders